Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Motley Fool49d agobullish
3 Reasons CRISPR Therapeutics Stock Is Still a Buy After a Rocky 2026Investor's Business Daily52d agobullish
Gene-Editing Powerhouse And Its Rivals Surge Toward A BreakoutMotley Fool55d agobullish
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool58d agobullish
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool58d agobullish
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool58d agobullish
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in SeptemberMotley Fool67d agobullish
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026Stocktwits97d agobullish
CRSP Stock Climbs After-Hours As CRISPR Maps Busy Second-Half Pipeline After Upbeat Q2Motley Fool125d agobullish
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?Stocktwits129d agobullish
CRSP, VRTX Stocks Surge As FDA Clears Casgevy For Children Ages 2 And UpInsider Monkey156d agobullish
CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline